Metrion Biosciences
Building B501
Babraham Research Campus
Cambridge
CB22 3AT
United Kingdom
Tel: 44-0-1223-919-100
Website: http://www.metrionbiosciences.com/
51 articles about Metrion Biosciences
-
Metrion Biosciences and The KCNC1 Foundation Collaborate on Development of New Ion Channel Modulators for Ultra-Rare Genetic Disorder
12/7/2022
Metrion Biosciences Limited and The KCNC1 Foundation announced a collaboration to progress a hit identification research project for small molecule modulators of the potassium ion channel Kv3.1, targeting KCNC1-related disorders.
-
Third Harmonic Bio, Akili Interactive, the Rare Disease Company Coalition, Inozyme, Athira, Cytovia and many more made major leadership decisions this week.
-
Metrion Biosciences Appoints Dr Benedetta Montagnini as Head of European Business Development
6/9/2022
Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, announced the appointment of Dr Benedetta Montagnini as Head of European Business Development.
-
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
Metrion Biosciences and Bioqube Ventures Collaborate on Venture Creation Project to Identify Novel Ion Channel Inhibitors for Autoimmune Diseases
12/16/2021
Metrion Biosciences Limited and Bioqube Ventures announced that they have entered into a collaboration, backed by Bioqube Factory Fund I, to incubate a drug discovery research project targeting autoimmune diseases.
-
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
Metrion Biosciences Expands Ion Channel Drug Discovery Service Capabilities and In-house Expertise
12/7/2021
Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, announced it has expanded its capabilities and expertise through the addition of automated low volume liquid handling capability and 384-well electrophysiology and fluorescence-based high throughput screening assay systems.
-
BioSpace Movers & Shakers, Dec. 3
12/3/2021
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
Metrion Biosciences Appoints Dr Rory Curtis as Vice President US Commercial Operations
11/30/2021
Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, announced the appointment of Dr Rory Curtis as Vice President US Commercial Operations.
-
Here’s a look at a few of the industry expansions that have been announced so far this month.
-
Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
-
Metrion Biosciences Expands Into New Headquarters to Support Continued Growth
9/22/2021
Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, announced that the Company has moved to larger, custom designed laboratory and office premises at Granta Park, Cambridge, UK.
-
BioSpace Movers & Shakers, July 30, 2021
7/30/2021
Biopharma and life science companies strengthen their leadership teams and boards with these Movers & Shakers. -
Metrion Biosciences appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development
7/26/2021
Metrion Biosciences Limited, the specialist ion channel contract research and drug discovery company, announced the appointment of Nick Foster as Chief Commercial Officer and Head of Global Business Development, to support the broadening of Metrion’s international customer base and facilitate entry into new territories.
-
Metrion Biosciences Appoints Mark Keogh as Non-Executive Director
4/19/2021
Appointment strengthens the financial and corporate experience of Metrion’s Board in support of the Company’s planned international growth
-
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
-
Metrion Biosciences Closes £2.7m New Equity Financing
4/6/2021
Metrion Biosciences Limited, the specialist ion channel CRO and drug discovery company, announced that it has secured £2.7m in new equity financing, including £2.25m from lead investor Gresham House Ventures.
-
BioSpace Movers & Shakers, Feb. 12
2/12/2021
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
Metrion Biosciences Appoints John Montana as Non-Executive Director
2/9/2021
Expansion of the Board of Directors will support the company’s further growth as an ion channels focused drug discovery CRO
-
Sosei Heptares to Explore Structure-based Drug Discovery (SBDD) Approaches to Ion Channels through Strategic Technology Collaboration with Metrion Biosciences
2/1/2021
Collaboration combines Sosei Heptares' leading structure-based drug design platform with Metrion Biosciences' ion channel expertise